Literature DB >> 11437493

An inhibitor of inducible nitric oxide synthase and scavenger of peroxynitrite prevents diabetes development in NOD mice.

W L Suarez-Pinzon1, J G Mabley, K Strynadka, R F Power, C Szabó, A Rabinovitch.   

Abstract

Peroxynitrite (ONOO(-)) is a highly reactive oxidant produced by the interaction of the free radicals superoxide (O*-2) and nitric oxide (NO(*)). In a previous study, we found that peroxynitrite is formed in islet beta-cells of nonobese diabetic (NOD) mice. Here, we report that guanidinoethyldisulphide (GED), a selective inhibitor of inducible nitric oxide synthase (iNOS) and scavenger of peroxynitrite prevents diabetes in NOD mice. GED treatment of female NOD mice, starting at age 5 weeks, delayed diabetes onset (from age 12 to 22 weeks) and significantly decreased diabetes incidence at 30 weeks (from 80% to 17%). GED did not prevent pancreatic islet infiltration by leukocytes; however, beta-cells that stained positive for nitrotyrosine (a marker of peroxynitrite) were significantly decreased in islets of GED-treated mice (1+/-1%) compared with vehicle-treated mice (30+/-9%). In addition, GED significantly inhibited nitric oxide and nitrotyrosine formation and decreased destruction of beta-cells in NOD mouse islets incubated in vitro with the combination of proinflammatory cytokines interleukin 1-beta (IL-1beta), tumour necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma). These findings indicate that both superoxide and nitric oxide radicals contribute to islet beta-cell destruction in autoimmune diabetes via peroxynitrite formation in the beta-cells. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11437493     DOI: 10.1006/jaut.2001.0507

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  28 in total

1.  In CD4+ T-cell-induced diabetes, macrophages are the final effector cells that mediate islet beta-cell killing: studies from an acute model.

Authors:  Boris Calderon; Anish Suri; Emil R Unanue
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

2.  SR-135, a peroxynitrite decomposing catalyst, enhances β-cell function and survival in B6D2F1 mice fed a high fat diet.

Authors:  Michael Johns; Robert Fyalka; Jennifer A Shea; William L Neumann; Smita Rausaria; Eliwaza Naomi Msengi; Maryam Imani-Nejad; Harry Zollars; Timothy McPherson; Joseph Schober; Joshua Wooten; Guim Kwon
Journal:  Arch Biochem Biophys       Date:  2015-04-29       Impact factor: 4.013

Review 3.  Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies.

Authors:  Pál Pacher; Irina G Obrosova; Jon G Mabley; Csaba Szabó
Journal:  Curr Med Chem       Date:  2005       Impact factor: 4.530

4.  Regulation of iNOS gene transcription by IL-1β and IFN-γ requires a coactivator exchange mechanism.

Authors:  Susan J Burke; Barrett L Updegraff; Rachel M Bellich; Matthew R Goff; Danhong Lu; Steven C Minkin; Michael D Karlstad; J Jason Collier
Journal:  Mol Endocrinol       Date:  2013-09-06

5.  Rpl13a small nucleolar RNAs regulate systemic glucose metabolism.

Authors:  Jiyeon Lee; Alexis N Harris; Christopher L Holley; Jana Mahadevan; Kelly D Pyles; Zeno Lavagnino; David E Scherrer; Hideji Fujiwara; Rohini Sidhu; Jessie Zhang; Stanley Ching-Cheng Huang; David W Piston; Maria S Remedi; Fumihiko Urano; Daniel S Ory; Jean E Schaffer
Journal:  J Clin Invest       Date:  2016-11-07       Impact factor: 14.808

6.  Cytokine toxicity in insulin-producing cells is mediated by nitro-oxidative stress-induced hydroxyl radical formation in mitochondria.

Authors:  Ewa Gurgul-Convey; Ilir Mehmeti; Stephan Lortz; Sigurd Lenzen
Journal:  J Mol Med (Berl)       Date:  2011-04-13       Impact factor: 4.599

7.  Transgenic expression of haem oxygenase-1 in pancreatic beta cells protects non-obese mice used as a model of diabetes from autoimmune destruction and prolongs graft survival following islet transplantation.

Authors:  S H Huang; C H Chu; J C Yu; W C Chuang; G J Lin; P L Chen; F C Chou; L Y Chau; H K Sytwu
Journal:  Diabetologia       Date:  2010-08-05       Impact factor: 10.122

8.  The novel inosine analogue, INO-2002, protects against diabetes development in multiple low-dose streptozotocin and non-obese diabetic mouse models of type I diabetes.

Authors:  Jon G Mabley; Pal Pacher; Kanneganti G K Murthy; William Williams; Garry J Southan; Andrew L Salzman; Csaba Szabo
Journal:  J Endocrinol       Date:  2008-06-18       Impact factor: 4.286

9.  Inosine protects against the development of diabetes in multiple-low-dose streptozotocin and nonobese diabetic mouse models of type 1 diabetes.

Authors:  Jon G Mabley; Alex Rabinovitch; Wilma Suarez-Pinzon; György Haskó; Pál Pacher; Robert Power; Gary Southan; Andrew Salzman; Csaba Szabó
Journal:  Mol Med       Date:  2003 Mar-Apr       Impact factor: 6.354

10.  In vitro and in vivo suppression of cellular activity by guanidinoethyl disulfide released from hydrogel microspheres composed of partially oxidized hyaluronan and gelatin.

Authors:  Lihui Weng; Natalia D Ivanova; Julia Zakhaleva; Weiliam Chen
Journal:  Biomaterials       Date:  2008-08-03       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.